Want to see TTRX full AI Analyst Report?

Turn Therapeutics Inc (TTRX) Financial Statements

20 Followers

Turn Therapeutics Inc Financial Overview

Turn Therapeutics Inc's market cap is currently $281.20M. The company's EPS TTM is $; its P/E ratio is -52.12; Turn Therapeutics Inc is scheduled to report earnings on ―, and the estimated EPS forecast is $―. See an overview of income statement, balance sheet, and cash flow financials.

	Mar 26	Dec 24	Dec 23
Income Statement
Total Revenue	$ 0.00	$ 0.00	$ 0.00
Gross Profit	$ 0.00	$ 0.00	$ 0.00
Operating Income	$ -5.86M	$ -1.80M	$ -2.31M
EBITDA	$ -3.14M	$ -1.72M	$ -2.25M
Net Income	$ -3.19M	$ -1.77M	$ -2.29M
Balance Sheet
Cash & Short-Term Investments	$ 5.08M	$ 872.60K	$ 1.18M
Total Assets	$ 12.16M	$ 2.05M	$ 2.01M
Total Debt	$ 80.38K	$ 121.04K	$ 25.16K
Net Debt	$ -5.00M	$ -751.56K	$ -1.16M
Total Liabilities	$ 7.48M	$ 2.23M	$ 1.93M
Stockholders' Equity	$ 4.69M	$ -177.43K	$ 85.77K
Cash Flow
Free Cash Flow	$ -2.72M	$ -1.46M	$ -1.42M
Operating Cash Flow	$ -2.56M	$ -1.36M	$ -1.38M
Investing Cash Flow	$ -152.99K	$ -99.47K	$ -44.31K
Financing Cash Flow	$ 6.92M	$ 1.15M	$ 500.00K

Currency in USD

Turn Therapeutics Inc Earnings and Revenue History

Income Statement >

Turn Therapeutics Inc Debt to Assets

Balance Sheet >

Turn Therapeutics Inc Cash Flow

Cash Flow >

Turn Therapeutics Inc Forecast EPS vs Actual EPS

Earnings >